Edwards Lifesciences Corporation (EW)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 86.96 |
| Open | 87.40 |
| Bid | 85.90 x 1100 |
| Ask | 87.85 x 800 |
| Day's range | 86.76 - 87.93 |
| 52-week range | 60.57 - 96.12 |
| Volume | |
| Avg. volume | 4,005,437 |
| Market cap | 52.819B |
| Beta (5Y monthly) | 1.07 |
| PE ratio (TTM) | 38.15 |
| EPS (TTM) | 2.30 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 94.52 |
ZacksDexCom (DXCM) to Report Q1 Earnings: What's in the Cards?
DexCom's (DXCM) first-quarter 2024 results are likely to reflect rising volumes across all channels.
ZacksIs a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?
West Pharmaceutical's (WST) first-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
ZacksUnveiling Edwards Lifesciences (EW) Q1 Outlook: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Edwards Lifesciences (EW), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
© 2024 Yahoo. All rights reserved.